ArticleThe open rheumatology journal2017

Dose Escalation and Co-therapy Intensification Between Etanercept, Adalimumab, and Infliximab: The CADURA Study.

Carter Thorne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.